Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v1-EN
Language French English
Date Updated 2020-04-03 2019-10-02
Drug Identification Number 02455366 02455366
Brand name TADALAFIL TADALAFIL
Common or Proper name TADALAFIL TADALAFIL
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients TADALAFIL TADALAFIL
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 4 4
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-10-02 2019-10-02
Estimated end date 2020-04-02 2020-02-03
Actual end date 2020-04-02
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments